Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Subsidiary update/news

$Evogene (EVGN.US)$ Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
37 MINUTES AGO, 7:00 AM EDT
VIA PR NEWSWIRE
The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application
REHOVOT, Israel, Sept. 30, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced receiving a grant from the Israel Innovation Authority (IIA) to advance its program to develop a breakthrough technology for the delivery of ag-biologicals to agriculture. This patented technology, named 'MicroFermentor', is based on an innovative microbe formulation that enables the multiplication of beneficial bacteria directly on the plant, reducing application costs, extending shelf life, and prolonging the bacteria's viability after field application. The grant was awarded following positive initial microbe encapsulation and greenhouse validation experiments and will support the program's next phase of development toward commercialization.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
+0
Translate
Report
3796 Views
Comment
Sign in to post a comment
    3468Followers
    27Following
    52KVisitors
    Follow